Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
These events were generally mild to moderate in severity and included: Nausea often accompanying changes in bowel habits, particularly after dose escalation Diarrhoea loose or watery stools, sometimes with urgency Vomiting less common but reported, especially at higher doses Constipation occurring in some individuals, reflecting the variable effect on gut motility Abdominal discomfort or bloating a sensation of fullness or cramping Flatulence increased wind, which can accompany altered digestion Gastrointestinal adverse events were the most common reason for discontinuation in the Phase 2 trial, occurring in approximately 510% of participants depending on dose group
J Intensive Care Med
The latest recommendations from DOCS Faculty on treating conscious sedation dental patients taking any of the increasingly popular weight loss prescription medications
R., Wu, J., Gigliotti, J
PMID: 29915025 Kurutas, E.B
US$ 20.49
US$ 26.14
US$ 27.10
US$ 27.29
US$ 24.56
US$ 23.14
US$ 22.49
